How Zinc May Help Premature Babies with Breathing Problems

Role Of Zinc As An Adjuvant In Preterm Neonates With Respiratory Distress - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105322

Enrollment

100

Registered

2026-03-03

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J840- Alveolar and parieto-alveolar conditions

Interventions

Intervention1: oral zinc sulphate: 2mg/kg/day for 7 Days Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Gestational age less than 37 completed weeks Presence of clinical respiratory distress Admission to SNCU or NICU during the study period Written informed consent obtained from parents or legal guardians

Exclusion criteria

Exclusion criteria: Congenital heart disease Major congenital anomalies Pulmonary hypoplasia Chromosomal abnormalities Refusal of consent by parents or guardians

Design outcomes

Primary

Measure	Time frame
The primary outcome measure was the change in severity of respiratory distress, as assessed by the Silverman Andersen score between Day 1 and Day 7Timepoint: 1 WEEK	—

Secondary

Measure	Time frame
Requirement & duration of respiratory support Clinical improvement Survival outcomeTimepoint: 1 week	—

Countries

India

Contacts

Public ContactDr Naresh Bajaj

Shyam Shah Medical College

naresh304052@gmail.com9399372171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026